Title:
血栓塞栓性疾患の予防および処置
Document Type and Number:
Japanese Patent JP2008528527
Kind Code:
A
Abstract:
The present invention relates to the field of blood coagulation, more specifically it relates to a method of treating a thromboembolic disorder by administering once daily a direct factor Xa inhibitor in oral dosage form to a patient in need thereof, wherein the factor Xa inhibitor has a plasma concentration half life indicative of a bid or tid administration interval, e.g. of 10 hours or less.
Inventors:
Michelbits, frank
Kubitua, Dagmar
Parc, Song Mi
Berlinck, Claus
Kubitua, Dagmar
Parc, Song Mi
Berlinck, Claus
Application Number:
JP2007552555A
Publication Date:
July 31, 2008
Filing Date:
January 19, 2006
Export Citation:
Assignee:
Bayer HealthCare AG
International Classes:
A61K45/00; A61K9/20; A61K31/5377; A61P7/02; A61P9/08; A61P9/10
Domestic Patent References:
| JP2003519141A | 2003-06-17 |
Attorney, Agent or Firm:
Patent business corporation Odashima patent office
Heikichi Odashima
Heikichi Odashima